Annual Revenue
$6.77 M
-$12.62 M-65.09%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual revenue is $6.77 million, with the most recent change of -$12.62 million (-65.09%) on December 31, 2023.
- During the last 3 years, LVTX annual revenue has risen by +$3.02 million (+80.65%).
- LVTX annual revenue is now -65.09% below its all-time high of $19.39 million, reached on December 31, 2022.
Performance
LVTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- LVTX quarterly revenue is not available.
Performance
LVTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- LVTX TTM revenue is not available.
Performance
LVTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
LVTX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.1% | - | - |
| 3 y3 years | +80.7% | - | - |
| 5 y5 years | - | - | - |
LVTX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -65.1% | +26.5% | ||||
| 5 y | 5-year | -65.1% | +80.7% | ||||
| alltime | all time | -65.1% | +80.7% |
LAVA Therapeutics NV Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $6.99 M(+1880.7%) | $12.54 M(+85.2%) |
| Dec 2023 | $6.77 M(-65.1%) | $353.00 K(+566.0%) | $6.77 M(-25.3%) |
| Sep 2023 | - | $53.00 K(-99.0%) | $9.06 M(-62.7%) |
| Jun 2023 | - | $5.14 M(+319.9%) | $24.26 M(+23.8%) |
| Mar 2023 | - | $1.22 M(-53.6%) | $19.59 M(+1.0%) |
| Dec 2022 | $19.39 M | $2.64 M(-82.7%) | $19.39 M(+8.8%) |
| Sep 2022 | - | $15.26 M(+3160.9%) | $17.82 M(+283.1%) |
| Jun 2022 | - | $468.00 K(-54.2%) | $4.65 M(-11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.02 M(-4.1%) | $5.26 M(+0.4%) |
| Dec 2021 | $5.35 M(+42.8%) | $1.07 M(-49.1%) | $5.24 M(-16.2%) |
| Sep 2021 | - | $2.10 M(+94.0%) | $6.26 M(+21.9%) |
| Jun 2021 | - | $1.08 M(+8.0%) | $5.13 M(+8.8%) |
| Mar 2021 | - | $1.00 M(-51.9%) | $4.72 M(+26.9%) |
| Dec 2020 | $3.75 M | $2.08 M(+114.3%) | $3.72 M(+127.1%) |
| Sep 2020 | - | $970.90 K(+45.8%) | $1.64 M(+145.8%) |
| Jun 2020 | - | $665.80 K | $665.80 K |
FAQ
- What is LAVA Therapeutics NV annual revenue?
- What is the all time high annual revenue for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual revenue year-on-year change?
- What is the all time high quarterly revenue for LAVA Therapeutics NV?
- What is the all time high TTM revenue for LAVA Therapeutics NV?
What is LAVA Therapeutics NV annual revenue?
The current annual revenue of LVTX is $6.77 M
What is the all time high annual revenue for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual revenue is $19.39 M
What is LAVA Therapeutics NV annual revenue year-on-year change?
Over the past year, LVTX annual revenue has changed by -$12.62 M (-65.09%)
What is the all time high quarterly revenue for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly revenue is $15.26 M
What is the all time high TTM revenue for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high TTM revenue is $24.26 M